EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 28.99 ($0.37) and traded as low as GBX 25 ($0.32). EKF Diagnostics shares last traded at GBX 25 ($0.32), with a volume of 144,190 shares trading hands.
EKF Diagnostics Stock Performance
The firm has a market capitalization of £113.43 million, a PE ratio of 2,500.00 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.59 and a debt-to-equity ratio of 1.78. The company has a 50-day moving average of GBX 28.46 and a 200 day moving average of GBX 28.99.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
See Also
- Five stocks we like better than EKF Diagnostics
- How to Evaluate a Stock Before Buying
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Top-Performing Non-Leveraged ETFs This Year
- How is Compound Interest Calculated?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
